Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-02-13 to 2025-02-14
Current total value of award: $4083.07
Description: 4567262349!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML